SAN ANTONIO, February 25, 2026--bioAffinity Technologies announced validation study with BAMC to assess deep suction sputum samples for lung cancer detection with CyPath Lung.
Early and accurate detection is critical for preventing the spread of COVID-19 and providing appropriate care for patients. Nasopharyngeal (NP) swabs, which require inserting a long shaft into the ...
bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced publication in the peer-reviewed Journal of Visualized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results